Documentation. Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in this Plan.

Documentation. All documents and other matters required by any of the provisions of this Agreement to be submitted or furnished to a Purchaser shall be in form and substance satisfactory to such Purchaser.

Documentation. Each Loan Party agrees to be bound by the terms of the Issuing Lender’s application and agreement for letters of credit and the Issuing Lender’s written regulations and customary practices relating to letters of credit, though such interpretation may be different from such Loan Party’s own. In the event of a conflict between such application or agreement and this Agreement, this Agreement shall govern. It is understood and agreed that, except in the case of gross negligence or willful misconduct, the Issuing Lender shall not be liable for any error, negligence and/or mistakes, whether of omission or commission, in following any Loan Party’s instructions or those contained in the Letters of Credit or any modifications, amendments or supplements thereto.

Documentation. The Lenders shall have received the following, duly executed by all the parties thereto, in form and substance reasonably satisfactory to the Lenders:

Documentation. The Administrative Agent’s receipt of the following, each of which shall be originals or telecopies or copies sent by electronic transmission (followed promptly by originals) unless otherwise specified, each properly executed by a Responsible Officer of the signing Loan Party (where applicable), each dated the Closing Date (or, in the case of certificates of governmental officials, a recent date before the Closing Date) and each in form and substance reasonably satisfactory to the Administrative Agent and each of the Lenders:

Documentation. The Award Agreement for a given Award, the Plan and any other documents may be delivered to, and accepted by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.

Documentation. The Administrative Agent or its counsel shall have received (including by way of electronic transmission) the following, duly executed by all the parties thereto, each in form and substance reasonably satisfactory to the Administrative Agent and the Lenders:

Documentation. The Purchaser shall have received, on or prior to the Second Closing Date, the following, each in form and substance satisfactory to the Purchaser and its counsel:

Co-Development. During the five year period following the Effective Date, in the event that Siemens upgrades an existing MRI system or develops a new MRI system that is intended # for global marketing, # to have specifications that are equivalent or superior to the specifications of the Avanto Dot System and # to be positioned in the same market field as the Avanto Dot System (any such upgraded or new MRI system, a “Next Generation MRI System”), Siemens shall notify [[ViewRay Parent:Organization]] as soon as commercially practicable following 510(k) approval by the U.S. Federal Drug Administration (“510(k)”). Upon receipt of such notice, [[ViewRay Parent:Organization]] shall have the option to co-develop with Siemens, on commercially reasonable terms to be agreed between [[ViewRay Parent:Organization]] and Siemens, any MR Linac applications of such Next Generation MRI System.

“Pharma Co. X” (a pseudonym) was a United States-based pharmaceutical company whose